申请人:Gilead Sciences, Inc.
                            
                            
                                公开号:EP3159345A1
                            
                            
                                公开(公告)日:2017-04-26
                            
                            
Compounds of Formula (IV), as well as pharmaceutically acceptable salts thereof, are disclosed:
The compounds are useful in the treatment of Hepatitis C infections.
                            本研究公开了式(IV)化合物及其药学上可接受的盐类:
这些化合物可用于治疗丙型肝炎感染。